China National Pharmaceutical Group

GPTKB entity

Predicate	Object
gptkbp:instanceOf	gptkb:biotechnology gptkb:state-owned_enterprise
gptkbp:alsoKnownAs	gptkb:Sinopharm
gptkbp:CEO	gptkb:Liu_Jingzhen
gptkbp:country	gptkb:China
gptkbp:focus	gptkb:organization manufacturing research and development retail pharmacy
gptkbp:founded	1998
gptkbp:headquartersLocation	gptkb:Beijing,_China
gptkbp:industry	healthcare pharmaceuticals
gptkbp:notableCompany	gptkb:Sinopharm_Group_Co.,_Ltd.
gptkbp:notableProduct	gptkb:Sinopharm_BIBP_COVID-19_vaccine gptkb:Sinopharm_WIBP_COVID-19_vaccine
gptkbp:numberOfEmployees	over 100,000
gptkbp:parentOrganization	gptkb:State-owned_Assets_Supervision_and_Administration_Commission_of_the_State_Council
gptkbp:products	pharmaceuticals medical devices vaccines healthcare services
gptkbp:rank	gptkb:Fortune_Global_500
gptkbp:revenue	over 500 billion RMB (2022)
gptkbp:servesArea	worldwide
gptkbp:stockExchange	Hong Kong Stock Exchange (for Sinopharm Group Co., Ltd.)
gptkbp:subsidiary	gptkb:China_National_Biotec_Group gptkb:China_National_Medicines_Corporation_Ltd. gptkb:Sinopharm_Group_Co.,_Ltd.
gptkbp:website	http://www.sinopharm.com/
gptkbp:bfsParent	gptkb:Shanghai_Stock_Exchange
gptkbp:bfsLayer	5
https://www.w3.org/2000/01/rdf-schema#label	China National Pharmaceutical Group